|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/715 | |
| C07K 19/00 | |||
| A61K 38/19 | |||
| A61K 38/17 | |||
| A61K 39/395 | |||
| A61K 38/20 | |||
| A61P 37/00 | |||
| A61P 43/00 | |||
| A61K 38/00 |
| (11) | Number of the document | 1173484 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00928591.7 |
| Date of filing the European patent application | 2000-04-28 | |
| (97) | Date of publication of the European application | 2002-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2000/011612 |
| Date | 2000-04-28 |
| (87) | Number | WO 2000/064944 |
| Date | 2000-11-02 |
| (30) | Number | Date | Country code |
| 301808 | 1999-04-28 | US |
| (72) |
WYNN, Thomas, A., US
CHIARAMONTE, Monica, G., US
COLLINS, Mary, US
DONALDSON, Debra, US
FITZ, Lori, US
NEBEN, Tamlyn, US
WHITTERS, Matthew, J., US
WOOD, Clive, US
|
| (73) |
Genetics Institute, LLC,
87 Cambridge Park Drive, Cambridge, MA 02140,
US
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852-3804, US |
| (54) | TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 AND IL-13 RECEPTOR CHAINS |
| TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 AND IL-13 RECEPTOR CHAINS |